Helio Logistics, Inc. v. Mehta

CourtDistrict Court, S.D. New York
DecidedJanuary 3, 2023
Docket7:22-cv-10047
StatusUnknown

This text of Helio Logistics, Inc. v. Mehta (Helio Logistics, Inc. v. Mehta) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Helio Logistics, Inc. v. Mehta, (S.D.N.Y. 2023).

Opinion

UNITED STATES DISTRICT COURT DOCUMENT SOUTHERN DISTRICT OF NEW YORK ECTROMESELY ELED DOC #: DATE FILED: 01/03/2023 __ HELIO LOGISTICS, INC. d/b/a NEXTMED, Plaintiff, -against- No. 22-cv-10047 (NSR)

APOORVA MEHTA, CLOUD HEALTH SYSTEMS OPINION & ORDER LLC d/b/a SUNRISE HEALTH, and TEJASVI SINGH Defendants.

NELSON S. ROMAN, United States District Judge: On December 20, 2022, Plaintiff Helio Logistics, Inc. d/b/a NextMed (“Plaintiff or “NextMed”) submitted to the Court an Order to Show Cause for a Temporary Restraining Order, Expedited Discovery, and Preliminary Injunction (the “Application”). (ECF No. 26.) The Court granted Plaintiffs Application that same day and set a Show Cause Hearing for December 22, 2022 (the “Hearing”). (ECF No. 26.) Defendants Mehta and Sunrise, and Defendant Singh, each opposed Plaintiff's Application, filing separate Cross Motions to Immediately Dissolve the December 20 Order to Show Cause (ECF Nos. 27 and 30, respectively). Specifically, the Application temporarily restrained Defendants, and anyone acting in concert with them, from: (1) using, disclosing, selling, copying, duplicating, or otherwise employing Plaintiff's trade secrets, including through using or employing any documents, files, platforms, websites, systems, or other information that is derived from Plaintiff's trade secrets; and

(2) erasing, replacing, destroying, transferring, moving, or otherwise disposing of Plaintiff’s trade secrets from their present location, absent further order of this Court. The Application also ordered limited, expedited discovery, including three (3) depositions and up

to ten (10) requests for production of documents on Defendants. (ECF No. 26.) In its Application, Plaintiff further sought a preliminary injunction restraining Defendants from (1) and (2), supra, in addition to restraining Defendants from: (3) making available or otherwise providing its websites, currently at https://www.findsunrise.com/ and https://app.findsunrise.com/, or any variations thereof, to the public, including to former, current, and prospective customers and investors, absent further order of this Court; and reproducing, counterfeiting, copying, or colorably imitating Plaintiff’s Marks and applying such reproductions, counterfeits, copies, or colorable imitations to digital images, labels, signs, prints, packages, wrappers, receptacles or advertisements intended to be used in commerce

upon or in connection with the sale, offering for sale, distribution, or advertising goods or services. (Id.) The Court has carefully reviewed the parties’ submissions and considered the arguments that each party made at the in-person hearing held on December 22, 2022. (ECF No. 43.) For the following reasons, Defendants Motions are GRANTED and the Application is dissolved, without prejudice for renewal upon an adequate showing of personal jurisdiction. FACTUAL BACKGROUND The following facts are taken from the parties’ submissions, including Plaintiff’s Verified Amended Complaint (“AC”) (ECF No. 22), Plaintiff’s Declaration of Robert Epstein (“Epstein Decl.”) (ECF No. 35), Plaintiff’s Memorandum of Law in Support of Plaintiff’s Application (“Plf. Mem.”) (ECF No. 33), Defendants Mehta and Sunrise’s Declaration of Apoorva Mehta (“Mehta Decl.”) (ECF No. 29), Defendants Mehta and Sunrise’s Memorandum of Law in Support of Their Cross Motion to Dissolve the December 20 Order to Show Cause (“Defs. Mem.”) (ECF No. 28),

Defendant Singh’s Memorandum of Law in Support of his Cross Motion to Dissolve the December 20 Order to Show Cause (“Def. Mem.”) (ECF No. 31), and Defendant Singh’s Declaration of Tejasvi Singh (“Singh Decl.”). (ECF No. 32.) The following facts are undisputed unless otherwise noted. See Park Irmat Drug Corp. v. OptumRx, Inc. 152 F.Supp.3d 127, 132 (S.D.N.Y. 2016) (“In deciding a motion for [a] preliminary injunction, a court may consider the entire record including affidavits and other hearsay evidence.”); see also 725 Eatery Corp. v. City of New York, 408 F.Supp.3d 424, 455 (S.D.N.Y. 2019) (quoting Charette v. Town of Oyster Bay, 159 F.3d 749, 755 (2d Cir. 1998)) (noting that, for purposes of a preliminary injunction, “a party is not entitled to have the court accept its untested representations as true if they are disputed”).

Founding of NextMed and Initial Interest from K5 Global In August 2020, Robert Epstein (“Epstein”) founded NextMed (“Plaintiff”), a healthcare startup connecting doctors and patients seeking weight-loss treatments and invited Defendant Tejasvi Singh (“Singh”) to join as a cofounder and business advisor. (AC ¶¶ 30−31, 33−34; Epstein Decl. ¶¶ 2-3, 6-7.). Singh signed a non-disclosure and confidentiality agreement in his capacity as an advisor. (AC ¶ 34, Ex. A (“Advisor Agreement”)); Epstein Decl. ¶ 6.) Singh’s role as an advisor included finding investments for Plaintiff. (AC ¶ 34; Epstein Decl. ¶ 6.) Although Singh left Plaintiff as a cofounder in the Spring of 2021, he remained an advisor to Plaintiff at least through August of 2022. (AC ¶¶ 41−43, 57; Epstein Decl. ¶¶ 11, 21.) After Singh left Plaintiff as a cofounder, Epstein headed the company. (AC ¶¶ 44, 47; Epstein Decl. ¶¶ 11−15.) In January 2022, venture capital firm K5 Global (“K5”) offered Plaintiff a term sheet to lead its seed round of investment for $3 million. (AC ¶ 47; Epstein Decl. ¶ 14.) Singh subsequently started working with K5 in May 2022. (AC ¶¶ 52−53; Epstein Decl. ¶ 16.)

Throughout the summer of 2022, K5 expressed interest in making additional investments in Plaintiff. (E.g., AC ¶¶ 56−57; Epstein Decl. ¶¶ 17−19.) As Singh remained an advisor to Plaintiff, he became the liaison between Plaintiff and K5, allegedly orchestrating K5’s due diligence of Plaintiff in advance of K5’s potential additional investment. (E.g., AC ¶¶ 52−53, 56−57; Epstein Decl. ¶¶ 16, 19−21.) Singh Allegedly Obtains Confidential Information from Plaintiff When Plaintiff’s business “took off” in May of 2022, Singh repeatedly asked Epstein for Plaintiff’s proprietary information; Singh asserted that K5 required it for its due diligence in order to determine whether it could offer additional funding to Plaintiff at a higher valuation than was previously contemplated. (E.g., AC ¶¶ 56−59, 64, 71−76; Epstein Decl. ¶¶ 17-20, 22, 30−31, 38,

42.) Epstein gave Singh the requested information because Singh was subject to confidentiality obligations to Plaintiff and Epstein believed Singh was acting as K5’s representative. (E.g., AC ¶¶ 52−53, 56−57; Epstein Decl. ¶¶ 19−21, 38.) Plaintiff claims that Epstein provided this information to Singh while Epstein and Singh were “often” working the same location, including Epstein’s apartment in New York City and from the Scarsdale home of Epstein’s parents in the late summer and Fall of 20221 (Compl. ¶ 52-59.) Plaintiff alleges that Singh stockpiled Plaintiff’s trade secrets for his and Defendant Apoorva Mehta’s (“Mehta”) later use, rather than for K5’s due diligence purposes. (E.g., AC ¶¶

1 At the Hearing, Plaintiff informed the Court that Epstein and his parents are residents of, and maintain their homes in, Scarsdale, New York. (ECF No. 43.) 80, 83, 87−89, 99−100, 104, 107; Epstein Decl. ¶¶ 36−38, 40−47.) Indeed, Plaintiff alleges that Singh gave its trade secrets to Mehta after Singh acquired them from Epstein. (E.g., AC ¶¶ 80, 84, 87−89, 99−100, 104, 107−108, 142; Epstein Decl. ¶¶ 36−37, 40−47, 51.) These trade secrets allegedly took two years and several million dollars to develop; they include Plaintiff’s client list,

web traffic and advertising data analytics, revenue mix, product mix, churn data, contact information, lifetime value, product discounts, demographics, sales patterns, customer acquisition costs, average revenue per unit, and channel-by-channel marketing analyses.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Salinger v. Colting
607 F.3d 68 (Second Circuit, 2010)
Penguin Group (USA) Inc. v. American Buddha
609 F.3d 30 (Second Circuit, 2010)
Chloé v. Queen Bee of Beverly Hills, LLC
616 F.3d 158 (Second Circuit, 2010)
John J. Fox v. Alfred G. Boucher
794 F.2d 34 (Second Circuit, 1986)
Cutco Industries, Inc. v. Dennis E. Naughton
806 F.2d 361 (Second Circuit, 1986)
Charette v. Town Of Oyster Bay
159 F.3d 749 (Second Circuit, 1998)
Thyroff v. Nationwide Mutual Insurance Company
460 F.3d 400 (Second Circuit, 2006)
Faiveley Transport Malmo AB v. Wabtec Corp.
559 F.3d 110 (Second Circuit, 2009)
Energy Brands Inc. v. Spiritual Brands, Inc.
571 F. Supp. 2d 458 (S.D. New York, 2008)
Roth v. El Al Israel Airlines, Ltd.
709 F. Supp. 487 (S.D. New York, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
Helio Logistics, Inc. v. Mehta, Counsel Stack Legal Research, https://law.counselstack.com/opinion/helio-logistics-inc-v-mehta-nysd-2023.